252 related articles for article (PubMed ID: 1841809)
1. [Ventricular hypertrophy as an expression of hypertensive damage].
Chiariello M; Betocchi S
Cardiologia; 1991 Dec; 36(12 Suppl 1):79-84. PubMed ID: 1841809
[TBL] [Abstract][Full Text] [Related]
2. [Left ventricular hypertrophy in hypertensive patients].
Amabile G
Ann Cardiol Angeiol (Paris); 1994 Sep; 43(7):408-13. PubMed ID: 7993037
[TBL] [Abstract][Full Text] [Related]
3. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
Ghanem Wisam MA; Murín J; Bulas J
Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
[TBL] [Abstract][Full Text] [Related]
4. Ambulatory 24-hour blood pressure monitoring: correlation between blood pressure variability and left ventricular hypertrophy in untreated hypertensive patients.
Feola M; Boffano GM; Procopio M; Reynaud S; Allemano P; Rizzi G
G Ital Cardiol; 1998 Jan; 28(1):38-44. PubMed ID: 9493044
[TBL] [Abstract][Full Text] [Related]
5. [Relation between left ventricular hypertrophy and retinal vascular changes in mild hypertension].
Pose Reino A; González-Juanatey JR; Castroviejo M; Valdés L; Estévez JC; Méndez I; Cabezas-Cerrato J
Med Clin (Barc); 1997 Mar; 108(8):281-5. PubMed ID: 9121203
[TBL] [Abstract][Full Text] [Related]
6. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications.
Devereux RB; de Simone G; Ganau A; Roman MJ
J Hypertens Suppl; 1994 Dec; 12(10):S117-27. PubMed ID: 7769482
[TBL] [Abstract][Full Text] [Related]
7. Ventricular arrhythmias and left ventricular hypertrophy in essential hypertension.
Palmiero P; Maiello M
Minerva Cardioangiol; 2000 Dec; 48(12):427-34. PubMed ID: 11253327
[TBL] [Abstract][Full Text] [Related]
8. [Antihypertensive treatment and left ventricular hypertrophy].
Agabiti-Rosei E; Muiesan ML; Rizzoni D
Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
[TBL] [Abstract][Full Text] [Related]
9. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Chinali M; de Simone G; Wachtell K; Gerdts E; Gardin JM; Boman K; Nieminen MS; Papademetriou V; Dahlöf B; Devereux RB
J Hypertens; 2008 Jul; 26(7):1472-6. PubMed ID: 18551025
[TBL] [Abstract][Full Text] [Related]
10. Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Wachtell K; Papademetriou V; Smith G; Gerdts E; Dahlöf B; Engblom E; Aurigemma GP; Bella JN; Ibsen H; Rokkedal J; Devereux RB
Am Heart J; 2004 Sep; 148(3):538-44. PubMed ID: 15389245
[TBL] [Abstract][Full Text] [Related]
11. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
Agabiti-Rosei E; Muiesan ML
J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular structure and function in previously untreated hypertensive patients: the importance of blood pressure, the nocturnal blood pressure dip and heart rate.
Mayet J; Shahi M; Hughes AD; Stanton AV; Poulter NR; Sever PS; Foale RA; Thom SA
J Cardiovasc Risk; 1995 Jun; 2(3):255-61. PubMed ID: 7584802
[TBL] [Abstract][Full Text] [Related]
13. [Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients].
Ito O; Okamoto M; Murakami Y; Nakayama R
J Cardiol; 1991; 21(4):931-41. PubMed ID: 1844449
[TBL] [Abstract][Full Text] [Related]
14. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Palmieri V; Okin PM; Bella JN; Wachtell K; Oikarinen L; Gerdts E; Boman K; Nieminen MS; Dahlöf B; Devereux RB
J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
[TBL] [Abstract][Full Text] [Related]
15. [Impact of arterial hypertension on the heart].
Herpin D
Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
[TBL] [Abstract][Full Text] [Related]
16. [Left ventricular performance and morphologic myocardial changes in untreated hypertensive patients].
du Cailar G; Ribstein J; Radauceanu A; Halimi JM; Mimran A
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1011-4. PubMed ID: 7755449
[TBL] [Abstract][Full Text] [Related]
17. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
Schmieder RE; Messerli FH
Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
[TBL] [Abstract][Full Text] [Related]
18. Reverse white-coat effect as an independent risk for left ventricular concentric hypertrophy in patients with treated essential hypertension.
Tomiyama M; Horio T; Kamide K; Nakamura S; Yoshihara F; Nakata H; Nakahama H; Kawano Y
J Hum Hypertens; 2007 Mar; 21(3):212-9. PubMed ID: 17167525
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
[TBL] [Abstract][Full Text] [Related]
20. Defining normal ambulatory blood pressure in relation to target organ damage and prognosis.
Verdecchia P; Porcellati C
Am J Hypertens; 1993 Jun; 6(6 Pt 2):207S-210S. PubMed ID: 8347320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
